Stephen P. Spielberg, M.D., Ph.D., is editor-in-chief of Therapeutic Innovation and Regulatory Science. Spielberg has served as a clinical associate in pediatrics at the Eunice Kennedy Shriver National Institute of Child Health and Human Development and director of clinical pharmacology and toxicology at The Hospital for Sick Children in Toronto. He also has served as vice president for pediatric drug development for Johnson & Johnson. His expertise in pediatric pharmacology, toxicology and therapeutic development is evidenced by his extensive publication record, which includes recent commentaries on therapeutic innovation and regulatory science, pediatric drug development and personalized medicine. His publications reflect his interest in therapeutics for child and maternal health worldwide.
Spielberg has published more than 140 scientific papers and received numerous awards for his work advancing pediatric therapeutics. He received his undergraduate degree in biology from Princeton and his M.D.-Ph.D. in pharmacology from the University of Chicago, completing an internship and his residency at Children’s Hospital Medical Center in Boston and a clinical fellowship in pediatrics at Harvard Medical School.